My watch list
my.bionity.com  
Login  

17 Newest Market Studies about the topic pulmonary arterial hypertension

rss

Letairis (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020

Introduction GlobalData’s pharmaceuticals report, “Letairis (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Letairis sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive ...

more

Remodulin (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020

Introduction GlobalData’s pharmaceuticals report, “Remodulin (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Remodulin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, ...

more

Tracleer (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020

Introduction GlobalData’s pharmaceuticals report, “Tracleer (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Tracleer sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive ...

more

Macitentan (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020

Introduction GlobalData’s pharmaceuticals report, “Macitentan (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Macitentan sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, ...

more

Veletri (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020

Introduction GlobalData’s pharmaceuticals report, “Veletri (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Veletri sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive ...

more

Revatio (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020

Introduction GlobalData’s pharmaceuticals report, “Revatio (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Revatio sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive ...

more

Pulmonary Arterial Hypertension - Pipeline Review, Q2 2011

Introduction Global Markets Direct’s, 'Pulmonary Arterial Hypertension - Pipeline Review, Q2 2011', provides an overview of the Pulmonary Arterial Hypertension therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Arterial Hypertension, complete ...

more

Page 2 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE